Form 4: Nuvalent Director Matthew Shair Sells Shares Under 10b5-1 Trading Plan

Director Matthew Shair of Nuvalent, Inc. executed sales of Class A Common Stock on June 24, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Matthew Shair, a director at Nuvalent, Inc., sold shares of Class A Common Stock on June 24, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 21, 2023.
• A total of 1,000 shares were sold directly at weighted average prices ranging from $78.88 to $81.15.
• An additional 1,810 shares held indirectly by the Matthew D. Shair 2021 Irrevocable Family Trust were sold at weighted average prices ranging from $78.88 to $81.15.
• Following these transactions, Shair directly owns 1,427,197 shares of Class A Common Stock and indirectly owns 232,522 shares through the family trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for executives and directors to utilize 10b5-1 trading plans to sell shares over time to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates